Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions
Clinical trial NCT02658422 · COMPLETED
Trial details
- NCT number
- NCT02658422
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-18
- Primary completion
- 2015-09-21
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.